共 270 条
[1]
Wang X(2014)Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice Mol Autism. 5 30-222
[2]
Xu Q(2016)The therapeutic potential of insulin-like growth Factor-1 in central nervous system disorders Neurosci Biobehav Rev 63 207-584
[3]
Bey AL(2003)Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms J Med Genet 40 575-27
[4]
Lee Y(2007)Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders Nat Genet 39 25-20
[5]
Jiang YH(2011)Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome PLoS Genetics 7 e1002173-859
[6]
Costales J(2018)Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations Mol Autism 9 1-320
[7]
Kolevzon A(2014)Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome Hum Genet 133 847-147
[8]
Wilson H(2013)Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency Mol Autism 4 18-581
[9]
Wong A(2014)Phelan-McDermid syndrome : a review of the literature and practice parameters for medical assessment and monitoring J Neurodev Disord 6 39-1659
[10]
Shaw S(2018)Prospective longitudinal overnight video-EEG evaluation in Phelan-McDermid Syndrome Epilepsy Behav 80 312-20